科研之友
微信
新浪微博
Facebook
分享链接
摘要
We have recently demonstrated that the administration of a plasmid coding for -enolase can elicit robust immune responses in genetically engineered mice that spontaneously develop pancreatic cancer, resulting in a significant improvement of their survival. This approach provides a springboard for the elaboration of new forms of immunotherapy for pancreatic cancer.
- 出版日期2013-6-1
